Semaglutide is the active ingredient in Ozempic and Rybelsus, and it is used to manage type 2 diabetes and obesity
At your appointment, we will take your health history, and our registered nurse will provide your therapy session
These compounds are not classified as drugs, supplements, food additives, or medical devices, and it is a violation of federal law to use these materials in humans or animals.
When an aqueous peptide solution freezes, ice crystals form within the liquid
"The FDA submission of CagriSema marks an important milestone and signals a new era in weight management, reinforcing Novo Nordisk's long-standing commitment to serving people living with obesity through innovation and science," said Mike Doustdar, president and CEO of Novo Nordisk
Can't ask for more heather G.Kingston, ONVerified